<DOC>
	<DOCNO>NCT00054067</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . It yet know regimen radiation therapy combine chemotherapy , without surgery , effective treat early cancer cervix . PURPOSE : Randomized phase III trial compare effectiveness surgery follow different regimen radiation therapy chemotherapy chemotherapy radiation therapy alone treat patient stage I cancer cervix .</brief_summary>
	<brief_title>Chemotherapy Radiation Therapy With Without Surgery Treating Patients With Stage I Cancer Cervix</brief_title>
	<detailed_description>OBJECTIVES : - Compare progression-free survival survival patient stage IB2 carcinoma cervix radical hysterectomy tailor chemoradiotherapy v primary chemoradiotherapy . - Compare toxicity regimens patient . - Compare health-related quality life patient treat regimen . OUTLINE : This randomize , multicenter study . Patients randomize 1 2 treatment arm . - Arm I : ( Surgery follow chemoradiotherapy ) : Patients undergo exploratory laparotomy follow radical hysterectomy bilateral pelvic para-aortic lymphadenectomy . Depending finding surgery , radical hysterectomy lymphadenectomy either complete aborted . - Aborted hysterectomy : Patients abort hysterectomy assign 1 3 group , depend finding surgery . - Group 1 : Within 4 week surgery , patient undergo pelvic radiotherapy 5 time weekly 4-6 week intracavitary irradiation external radiotherapy . Patients also receive concurrent cisplatin IV 1 hour weekly total 5-6 dos . - Group 2 : Patients receive radiotherapy cisplatin group 1 additional extend field radiotherapy . - Group 3 : Patients receive treatment discretion investigator . - Completed hysterectomy : Patients complete radical hysterectomy assign 1 3 group , depend finding surgery . - Group A : Patients receive treatment group 1 without intracavity irradiation . - Group B : Patients receive treatment group 2 without intracavity irradiation . - Group C : Patients receive treatment . - Arm II ( Primary chemoradiotherapy ) : Patients undergo pelvic radiotherapy 5 time weekly 4-6 week intracavity irradiation external radiotherapy . Patients also receive concurrent cisplatin IV 1 hour weekly total 6 dos . Quality life assess baseline , week 5 therapy , 3 , 6 , 12 month . Patients follow every 3 month 2 year , every 6 month 3 year , annually thereafter . PROJECTED ACCRUAL : A total 740 patient ( 370 per treatment arm ) accrue study within 7.5 year .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm stage IB2 invasive carcinoma uterine cervix one follow type : Squamous cell carcinoma Adenocarcinoma Adenosquamous carcinoma Primary , previously untreated disease Exophytic cervical lesion great 4 cm diameter OR Cervical expansion great 4 cm diameter , presume result principal involvement cancer No evidence extrauterine disease pelvic lymph node involvement ( clinical radiographic examination ) No paraaortic lymph nodal disease ( suspect CT scan , MRI , positronemission tomography , lymphangiogram ) unless node confirm pathologically negative ( CTguided biopsy extraperitoneal lymph node dissection ) Eligible radical hysterectomy lymph node dissection PATIENT CHARACTERISTICS : Age 18 Performance status GOG 02 Life expectancy Not specify Hematopoietic Absolute neutrophil count least 1,500/mm^3 Platelet count least 100,000/mm^3 Hepatic Bilirubin great 1.5 time normal SGOT great 3 time normal Alkaline phosphatase great 3 time normal Renal Creatinine great 2.0 mg/dL No renal abnormality require modification radiation field Gastrointestinal No gastrointestinal bleeding No intestinal obstruction Other Not pregnant Negative pregnancy test No septicemia severe infection No invasive malignancy evidence disease within past 5 year except nonmelanoma skin cancer No circumstance would preclude study completion require followup PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy No prior chemotherapy Endocrine therapy Not specify Radiotherapy No prior radiotherapy Surgery See Disease Characteristics No prior hysterectomy ( total subtotal )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>cervical adenocarcinoma</keyword>
	<keyword>cervical adenosquamous cell carcinoma</keyword>
	<keyword>cervical squamous cell carcinoma</keyword>
	<keyword>stage IB cervical cancer</keyword>
</DOC>